3,4-methylenedioxyamphetamine has been researched along with ritanserin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbate, GM; Nieduzak, TR; Schmidt, CJ; Taylor, VL | 1 |
Gibb, JW; Hanson, GR; Johnson, M | 1 |
Bush, LG; Gibb, JW; Hanson, GR; Johnson, M | 1 |
Colado, MI; Elliott, JM; Esteban, B; Green, AR; Mechan, AO; O'Shea, E | 1 |
4 other study(ies) available for 3,4-methylenedioxyamphetamine and ritanserin
Article | Year |
---|---|
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Anti-Arrhythmia Agents; Brain; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Homovanillic Acid; Levodopa; Male; Nomifensine; Piperidines; Rats; Rats, Inbred Strains; Ritanserin; Serotonin Antagonists; Stereoisomerism; Time Factors | 1991 |
Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Haloperidol; Male; Methamphetamine; Methiothepin; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Ritanserin; Serotonin Antagonists | 1988 |
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Designer Drugs; Dynorphins; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotensin; Rats; Rats, Sprague-Dawley; Ritanserin; Serotonin | 1993 |
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Animals; Benzazepines; Body Temperature; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Fever; Hallucinogens; Hippocampus; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Remoxipride; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2002 |